Axial Spondyloarthritis Clinical Trials
6 recruiting trials for Axial Spondyloarthritis. Eligibility criteria explained in plain English.
TrialFinderData lists 6 Axial Spondyloarthritis clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Across the trials that carry a phase, Phase 1 is the largest group at 67% (2 studies); the largest phase groups are Phase 1: 2, Phase 4: 1.
Research is led by The Danish Center for Expertise in Rheumatology (2), UCB Biopharma SRL (2), University of Sao Paulo General Hospital (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is WORK-ON (other, 1 trial), followed by Interdisciplinary Nurse-coordinated self-management support for people with inflammatory arthritis and substantial disease impact, Bimekizumab regimen 1 iv.
Track Axial Spondyloarthritis trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
WORK-ON Vocational Rehabilitation for People with Inflammatory Arthritis
People with chronic inflammatory arthritis (IA) (rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis), often have a reduced work ability. Up to 40% lose their...
INSELMA - a Randomised Controlled Trial
Background: Patients with inflammatory arthritis (IA) experience substantial impact of their disease despite optimal pharmacological treatment. To be able to manage these...
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in...
To demonstrate that bimekizumab administered intravenously is noninferior to subcutaneous administration.
Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
The goal of this clinical trial is to evaluate whether the live attenuated tetravalent Butantan-Dengue vaccine (Butantan-DV) is safe and capable of inducing an immune response in...
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx®...
Primary purpose of the study is to assess the concentration of bimekizumab in mature human breast milk.
Osteosarcopenia in Axial Spondyloarthritis
Axial spondyloarthritis is a chronic inflammatory disease affecting the spine, sacroiliac joints, entheses, and sometimes peripheral joints with a close link to HLAB27. Typical...
Explore Other Conditions
Frequently Asked Questions
There are currently 6 clinical trials for Axial Spondyloarthritis, with 6 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Axial Spondyloarthritis, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Axial Spondyloarthritis, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.